ArticleJTO clinical and research reports2023

Avelumab in Combination With Cetuximab and Chemotherapy as First-Line Treatment for Patients With Advanced Squamous NSCLC.

Zoran Andric et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.